My Quote Request
6505-01-067-2750
20 Products
NDC50111-0390-02
SALSALATE TABLETS,USP
NSN, MFG P/N
6505010672750
NSN
6505-01-067-2750
NDC50111-0390-02
SALSALATE TABLETS,USP
NSN, MFG P/N
6505010672750
NSN
6505-01-067-2750
MFG
PLIVA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS SALSALATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALALATE TABLETS 500MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
2402
CARBENICILLIN DISODIUM,USP
NSN, MFG P/N
6505010672809
NSN
6505-01-067-2809
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 30.000 GRAMS CARBENICILLIN
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 30.000 GRAMS CARBENICILLIN
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
GEOPEN IV
CARBENICILLIN DISODIUM,USP
NSN, MFG P/N
6505010672809
NSN
6505-01-067-2809
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 30.000 GRAMS CARBENICILLIN
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 30.000 GRAMS CARBENICILLIN
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00049-1322-83
CARBENICILLIN DISODIUM,USP
NSN, MFG P/N
6505010672809
NSN
6505-01-067-2809
NDC00049-1322-83
CARBENICILLIN DISODIUM,USP
NSN, MFG P/N
6505010672809
NSN
6505-01-067-2809
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: EQUIVALENT TO 30.000 GRAMS CARBENICILLIN
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: POWDER SUFFICIENT TO YIELD 30.000 GRAMS CARBENICILLIN
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
3011
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010672810
NSN
6505-01-067-2810
3011
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010672810
NSN
6505-01-067-2810
MFG
CORD LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3-PART LABEL ON BOTTLE
Related Searches:
NDC00005-3291-32
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010672810
NSN
6505-01-067-2810
NDC00005-3291-32
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010672810
NSN
6505-01-067-2810
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3-PART LABEL ON BOTTLE
Related Searches:
NDC49335-3011-66
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010672810
NSN
6505-01-067-2810
NDC49335-3011-66
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505010672810
NSN
6505-01-067-2810
MFG
CORD LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 3-PART LABEL ON BOTTLE
Related Searches:
82-255
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
82-255
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
MFG
REDI PRODUCTS DIV OF GENERAL MEDICAL MFG CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V POVIDONE-IODINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POVIDONE-IODINE TOPICAL SOLUTION USP 4 FL OZ BT WITH DISPENSER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DISPENSER CAP
SPECIAL FEATURES: EQUIVALENT TO 0.1 PERCENT W/V AVAILABLE IODINE
Related Searches:
BETADINE
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
BETADINE
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V POVIDONE-IODINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POVIDONE-IODINE TOPICAL SOLUTION USP 4 FL OZ BT WITH DISPENSER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DISPENSER CAP
SPECIAL FEATURES: EQUIVALENT TO 0.1 PERCENT W/V AVAILABLE IODINE
Related Searches:
BETADINE SOLUTION
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
BETADINE SOLUTION
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V POVIDONE-IODINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POVIDONE-IODINE TOPICAL SOLUTION USP 4 FL OZ BT WITH DISPENSER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DISPENSER CAP
SPECIAL FEATURES: EQUIVALENT TO 0.1 PERCENT W/V AVAILABLE IODINE
Related Searches:
NDC52380-1905-04
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
NDC52380-1905-04
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
MFG
APLICARE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V POVIDONE-IODINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POVIDONE-IODINE TOPICAL SOLUTION USP 4 FL OZ BT WITH DISPENSER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DISPENSER CAP
SPECIAL FEATURES: EQUIVALENT TO 0.1 PERCENT W/V AVAILABLE IODINE
Related Searches:
NDC67618-0150-04
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
NDC67618-0150-04
POVIDONE-IODINE TOPICAL SOLUTION,USP
NSN, MFG P/N
6505010672812
NSN
6505-01-067-2812
MFG
THE FREDERICK PURDUE COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V POVIDONE-IODINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: POVIDONE-IODINE TOPICAL SOLUTION USP 4 FL OZ BT WITH DISPENSER
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DISPENSER CAP
SPECIAL FEATURES: EQUIVALENT TO 0.1 PERCENT W/V AVAILABLE IODINE
Related Searches:
F0338062703
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010672813
NSN
6505-01-067-2813
F0338062703
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010672813
NSN
6505-01-067-2813
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: PERCENTAGE,W/V AMINO ACID ACTIVE INGREDIENT 3.500
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00338-0627-03
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010672813
NSN
6505-01-067-2813
NDC00338-0627-03
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010672813
NSN
6505-01-067-2813
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: PERCENTAGE,W/V AMINO ACID ACTIVE INGREDIENT 3.500
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
TRAVASOL M
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010672813
NSN
6505-01-067-2813
TRAVASOL M
AMINO ACIDS INJECTION WITH ELECTROLYTES
NSN, MFG P/N
6505010672813
NSN
6505-01-067-2813
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: PERCENTAGE,W/V AMINO ACID ACTIVE INGREDIENT 3.500
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00009-0233-01
BACITRACIN,USP
NSN, MFG P/N
6505010673977
NSN
6505-01-067-3977
MFG
PFIZER PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50000.000 UNITS BACITRACIN ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BACITRACIN STERILE USP 50000 UNITS PER BOTTLE
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 50000.000 UNITS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: IN 50 ML MULTIPLE DOSE BOTTLE
Related Searches:
2A6003
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.250 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PCT W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/INTRAVENOUS INJECTION SET
Related Searches:
490-16
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.250 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PCT W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/INTRAVENOUS INJECTION SET
Related Searches:
INTRALIPID 10 PCT
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
INTRALIPID 10 PCT
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.250 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PCT W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/INTRAVENOUS INJECTION SET
Related Searches:
NDC00161-0490-16
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
NDC00161-0490-16
FAT EMULSION INJECTION
NSN, MFG P/N
6505010674822
NSN
6505-01-067-4822
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.250 PERCENTAGE, V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE, V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.200 PCT W/V EGG YOLK PHOSPHOLIPIDS ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: W/INTRAVENOUS INJECTION SET